1. Home
  2. LAB vs DGICB Comparison

LAB vs DGICB Comparison

Compare LAB & DGICB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LAB
  • DGICB
  • Stock Information
  • Founded
  • LAB 1999
  • DGICB 1986
  • Country
  • LAB United States
  • DGICB United States
  • Employees
  • LAB N/A
  • DGICB N/A
  • Industry
  • LAB Biotechnology: Laboratory Analytical Instruments
  • DGICB Property-Casualty Insurers
  • Sector
  • LAB Industrials
  • DGICB Finance
  • Exchange
  • LAB Nasdaq
  • DGICB Nasdaq
  • Market Cap
  • LAB 504.2M
  • DGICB 562.0M
  • IPO Year
  • LAB 2011
  • DGICB N/A
  • Fundamental
  • Price
  • LAB $1.27
  • DGICB $15.33
  • Analyst Decision
  • LAB Buy
  • DGICB
  • Analyst Count
  • LAB 2
  • DGICB 0
  • Target Price
  • LAB $2.50
  • DGICB N/A
  • AVG Volume (30 Days)
  • LAB 1.6M
  • DGICB 1.2K
  • Earning Date
  • LAB 11-04-2025
  • DGICB 10-30-2025
  • Dividend Yield
  • LAB N/A
  • DGICB 4.18%
  • EPS Growth
  • LAB N/A
  • DGICB 965.80
  • EPS
  • LAB N/A
  • DGICB 2.34
  • Revenue
  • LAB $172,271,000.00
  • DGICB $993,644,532.00
  • Revenue This Year
  • LAB N/A
  • DGICB $2.26
  • Revenue Next Year
  • LAB N/A
  • DGICB $3.46
  • P/E Ratio
  • LAB N/A
  • DGICB $8.23
  • Revenue Growth
  • LAB 76.33
  • DGICB 3.36
  • 52 Week Low
  • LAB $0.92
  • DGICB $13.19
  • 52 Week High
  • LAB $2.32
  • DGICB $20.46
  • Technical
  • Relative Strength Index (RSI)
  • LAB 45.10
  • DGICB 49.50
  • Support Level
  • LAB $1.24
  • DGICB $14.87
  • Resistance Level
  • LAB $1.44
  • DGICB $15.87
  • Average True Range (ATR)
  • LAB 0.08
  • DGICB 0.27
  • MACD
  • LAB -0.00
  • DGICB 0.11
  • Stochastic Oscillator
  • LAB 10.32
  • DGICB 33.76

About LAB Standard BioTools Inc.

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.

About DGICB Donegal Group Inc. Class B

Donegal Group Inc is an insurance holding company that offers businesses and individuals personal and commercial lines of property and casualty insurance. The company's reportable segments are its Investment function, Personal lines of insurance, and Commercial lines of insurance. Personal lines products consist mainly of homeowners and private passenger automobile policies. The Commercial lines products of its insurance subsidiaries consist mainly of commercial automobile, commercial multi-peril, and workers' compensation policies. The group mainly operates in the United States.

Share on Social Networks: